Ranger Investment Management, L.P. Neogenomics Inc Transaction History

Ranger Investment Management, L.P.

$1.52 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.06 - $13.97 $5.48 Million - $10.8 Million	-776,428 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$12.15 - $35.28 $243,583 - $707,293	20,048 Added 2.65%	776,428 $9.43 Million
Q4 2021 Feb 11, 2022	SELL	$30.49 - $48.49 $1.66 Million - $2.65 Million	-54,576 Reduced 6.73%	756,380 $25.8 Million
Q3 2021 Nov 15, 2021	SELL	$41.66 - $52.52 $888,607 - $1.12 Million	-21,330 Reduced 2.56%	810,956 $39.1 Million
Q2 2021 Aug 16, 2021	SELL	$36.62 - $51.69 $709,732 - $1 Million	-19,381 Reduced 2.28%	832,286 $37.6 Million
Q1 2021 May 17, 2021	SELL	$41.56 - $59.88 $3.73 Million - $5.38 Million	-89,768 Reduced 9.54%	851,667 $41.1 Million
Q4 2020 Feb 12, 2021	SELL	$36.08 - $56.47 $11.7 Million - $18.4 Million	-325,520 Reduced 25.69%	941,435 $50.7 Million
Q3 2020 Nov 16, 2020	SELL	$33.26 - $40.48 $353,952 - $430,788	-10,642 Reduced 0.83%	1,266,955 $46.7 Million
Q2 2020 Aug 14, 2020	BUY	$24.21 - $31.02 $9.35 Million - $12 Million	386,329 Added 43.35%	1,277,597 $39.6 Million
Q1 2020 May 15, 2020	SELL	$20.5 - $34.53 $6.13 Million - $10.3 Million	-298,897 Reduced 25.11%	891,268 $24.6 Million
Q4 2019 Feb 14, 2020	BUY	$18.96 - $29.84 $1.1 Million - $1.74 Million	58,271 Added 5.15%	1,190,165 $34.8 Million
Q3 2019 Nov 14, 2019	SELL	$19.12 - $26.24 $1.47 Million - $2.01 Million	-76,726 Reduced 6.35%	1,131,894 $21.6 Million
Q2 2019 Aug 14, 2019	SELL	$19.57 - $24.1 $17,906 - $22,051	-915 Reduced 0.08%	1,208,620 $26.5 Million
Q1 2019 May 15, 2019	SELL	$12.14 - $20.46 $2.62 Million - $4.42 Million	-216,185 Reduced 15.16%	1,209,535 $24.7 Million
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $2.28 Million - $3.76 Million	203,085 Added 16.61%	1,425,720 $18 Million
Q3 2018 Nov 14, 2018	BUY	$12.5 - $15.38 $13.1 Million - $16.1 Million	1,048,405 Added 601.74%	1,222,635 $18.8 Million
Q2 2018 Aug 14, 2018	SELL	$7.99 - $14.05 $244,374 - $429,719	-30,585 Reduced 14.93%	174,230 $2.28 Million
Q1 2018 May 15, 2018	BUY	$7.23 - $8.76 $292,851 - $354,823	40,505 Added 24.65%	204,815 $1.67 Million
Q4 2017 Feb 13, 2018	BUY	$8.02 - $11.18 $85,814 - $119,626	10,700 Added 6.97%	164,310 $1.46 Million
Q3 2017 Nov 14, 2017	BUY	$9.11 - $11.26 $1.4 Million - $1.73 Million	153,610	153,610 $1.71 Million

Others Institutions Holding NEO

# of Institutions

294

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

Black Rock Inc. New York, NY

19.7M
Shares

$323 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14M
Shares

$230 Million
0.0% of portfolio
Brown Advisory Inc

6.89M
Shares

$113 Million
0.13% of portfolio
Janus Henderson Group PLC London, X0

6.6M
Shares

$108 Million
0.05% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.54M
Shares

$107 Million
0.06% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.06B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ranger Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ranger Investment Management, L.P. with notifications on news.

Account